Ashwini Pai

734 total citations
9 papers, 591 citations indexed

About

Ashwini Pai is a scholar working on Genetics, Nephrology and Oncology. According to data from OpenAlex, Ashwini Pai has authored 9 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Nephrology and 3 papers in Oncology. Recurrent topics in Ashwini Pai's work include Parathyroid Disorders and Treatments (4 papers), Dermatological and Skeletal Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ashwini Pai is often cited by papers focused on Parathyroid Disorders and Treatments (4 papers), Dermatological and Skeletal Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ashwini Pai collaborates with scholars based in United States. Ashwini Pai's co-authors include Cecilia M. Giachelli, Mohga El‐Abbadi, Elizabeth M. Leaf, Hayat Önyüksel, Sharon M. Moe, Wei Ling Lau, Israel Rubinstein, Bryan Bartley, Hung‐Wei Liao and Hsueh-Ying Yang and has published in prestigious journals such as Gastroenterology, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Ashwini Pai

9 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwini Pai United States 7 354 159 113 107 100 9 591
Payton Price United States 3 140 0.4× 63 0.4× 209 1.8× 100 0.9× 172 1.7× 4 616
Sonia Nasi Switzerland 15 213 0.6× 32 0.2× 15 0.1× 398 3.7× 318 3.2× 33 784
Véronique Chobaz Switzerland 10 182 0.5× 36 0.2× 14 0.1× 263 2.5× 312 3.1× 18 645
Xian Xue China 11 154 0.4× 22 0.1× 24 0.2× 18 0.2× 304 3.0× 16 649
Indira V. Kurup United States 10 95 0.3× 50 0.3× 15 0.1× 135 1.3× 84 0.8× 12 374
Gwon‐Soo Jung South Korea 15 90 0.3× 46 0.3× 9 0.1× 15 0.1× 229 2.3× 27 591
Leijun Hu United States 10 24 0.1× 105 0.7× 35 0.3× 79 0.7× 467 4.7× 20 835
Yuxi Wang China 14 160 0.5× 13 0.1× 14 0.1× 15 0.1× 198 2.0× 30 641
Beth A. Derfus United States 10 164 0.5× 72 0.5× 8 0.1× 311 2.9× 111 1.1× 13 560
Sílvia Carbonell Sala Italy 12 24 0.1× 115 0.7× 20 0.2× 36 0.3× 391 3.9× 28 857

Countries citing papers authored by Ashwini Pai

Since Specialization
Citations

This map shows the geographic impact of Ashwini Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwini Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwini Pai more than expected).

Fields of papers citing papers by Ashwini Pai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwini Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwini Pai. The network helps show where Ashwini Pai may publish in the future.

Co-authorship network of co-authors of Ashwini Pai

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwini Pai. A scholar is included among the top collaborators of Ashwini Pai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwini Pai. Ashwini Pai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Long, Millie D., Gary R. Lichtenstein, Jonathan Calkwood, et al.. (2022). 15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS. Gastroenterology. 162(7). S–5. 2 indexed citations
2.
Cross, Raymond K., Jonathan Calkwood, Ashwini Pai, et al.. (2021). P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis. The American Journal of Gastroenterology. 116(1). S9–S10. 6 indexed citations
3.
Wallace, Katrine L., et al.. (2020). The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian Cancer. PharmacoEconomics. 39(2). 231–241. 1 indexed citations
4.
Lau, Wei Ling, Ashwini Pai, Sharon M. Moe, & Cecilia M. Giachelli. (2011). Direct Effects of Phosphate on Vascular Cell Function. Advances in Chronic Kidney Disease. 18(2). 105–112. 92 indexed citations
5.
Pai, Ashwini, Elizabeth M. Leaf, Mohga El‐Abbadi, & Cecilia M. Giachelli. (2011). Elastin Degradation and Vascular Smooth Muscle Cell Phenotype Change Precede Cell Loss and Arterial Medial Calcification in a Uremic Mouse Model of Chronic Kidney Disease. American Journal Of Pathology. 178(2). 764–773. 141 indexed citations
6.
Pai, Ashwini & Cecilia M. Giachelli. (2010). Matrix Remodeling in Vascular Calcification Associated with Chronic Kidney Disease. Journal of the American Society of Nephrology. 21(10). 1637–1640. 63 indexed citations
7.
El‐Abbadi, Mohga, Ashwini Pai, Elizabeth M. Leaf, et al.. (2009). Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney International. 75(12). 1297–1307. 181 indexed citations
8.
Rubinstein, Israel, et al.. (2008). Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer. Nanomedicine Nanotechnology Biology and Medicine. 5(2). 178–183. 40 indexed citations
9.
Pai, Ashwini, Israel Rubinstein, & Hayat Önyüksel. (2006). PEGylated phospholipid nanomicelles interact with β-amyloid(1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro. Peptides. 27(11). 2858–2866. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026